USE OF AGOMELATINE IN OBTAINING MEDICAMENTS INTENDED FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER (OCD)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120309838A1
SERIAL NO

13578383

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of Obsessive-Compulsive Disorder (OCD).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LES LABORATOIRES SERVIER35 RUE DE VERDUN 92284 SURESNES CEDEX CEDEX

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Laigle, Laurence Maisons Laffitte, FR 1 0
Millan, Mark Le Pecq, FR 58 364
Mocaer, Elisabeth Neuily Sur Seine, FR 7 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation